bpc 157 human studies evidence BPC-157 and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Pharmacological overview of BPC-157. The
Description
The Therapeutic Goods Administration (TGA) lists other synthetic peptides not yet approved for human consumption, such as BPC-157, as Schedule 4 poisons
Des(1-3)IGF-I: A truncated form of insulin-like growth Factor-I

This modification holds significance in binding positively charged residues of proteins, thereby enhancing the capacity of the modified HA to carry peptide drugs

Not dosing advice and not for human or animal administration
